Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.57 - $0.99 $2,508 - $4,356
4,400 Added 10.76%
45,300 $37,000
Q1 2023

May 15, 2023

SELL
$0.51 - $0.78 $45,696 - $69,888
-89,600 Reduced 68.66%
40,900 $24,000
Q4 2022

Feb 14, 2023

SELL
$0.47 - $17.22 $42,453 - $1.56 Million
-90,326 Reduced 40.9%
130,500 $71,000
Q3 2022

Nov 14, 2022

SELL
$0.74 - $15.01 $444,415 - $9.01 Million
-600,561 Reduced 73.12%
220,826 $155,000
Q2 2022

Aug 15, 2022

BUY
$0.71 - $2.43 $47,374 - $162,141
66,725 Added 8.84%
821,387 $809,000
Q1 2022

May 16, 2022

BUY
$2.31 - $5.13 $561,780 - $1.25 Million
243,195 Added 47.55%
754,662 $1.8 Million
Q4 2021

Feb 14, 2022

BUY
$4.45 - $8.09 $1.95 Million - $3.55 Million
439,067 Added 606.45%
511,467 $2.43 Million
Q3 2021

Nov 16, 2021

SELL
$6.94 - $8.85 $1.51 Million - $1.92 Million
-216,901 Reduced 74.97%
72,400 $567,000
Q2 2021

Aug 16, 2021

BUY
$7.45 - $16.27 $192,575 - $420,563
25,849 Added 9.81%
289,301 $2.33 Million
Q1 2021

May 17, 2021

SELL
$8.78 - $12.8 $881,353 - $1.28 Million
-100,382 Reduced 27.59%
263,452 $2.98 Million
Q4 2020

Feb 16, 2021

BUY
$1.08 - $8.2 $192,492 - $1.46 Million
178,234 Added 96.03%
363,834 $2.98 Million
Q3 2020

Nov 16, 2020

BUY
$0.95 - $1.42 $176,320 - $263,552
185,600 New
185,600 $0

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.